Therapies directed towards blocking Fra-1 and c-Fos expression are promising moreover if it is considered that these proteins are normally down-regulated in normal breast cell growth but become up-regulated during, and are causally related to, breast cancer progression. Here, FOSL1 is linked to breast carcinoma.